Renal Filtration, Transport, and Metabolism of Albumin and Albuminuria

Seldin and Giebisch's The Kidney: Physiology & Pathophysiology 1-2

Volumn , Issue , 2007, Pages 2081-2112

  Osicka, Tanya M ^a,b   Russo, Osicka ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34247177705     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088488-9.50077-2     Document Type: Chapter

References (366)

1. Abbate M., Remuzzi G. Novel mechanism(s) implicated in tubular albumin reabsorption and handling. Am J Kidney Dis 2001, 38:196-204.
2. Agarwal R. On the nature of proteinuria with acute renal injury in patients with chronic renal disease. Am J Physiol 2005, 288:F265-F271.
3. Agewall S., Persson B., Samuelsson O., et al. Microalbuminuria in treated hypertensive men at high risk of coronary disease. J Hypertens 1993, 11:461-469.
4. Agrawal B., Berger A., Wolf K., et al. Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension. J Hypertens 1996, 14:223-228.
5. Alfino P.A., Neugarten J., Schacht R.G., et al. Glomerular size-selective barrier dysfunction in nephrotoxic serum nephritis. Kidney Int 1988, 34:151-155.
6. Allain F., Vanpouille C., Denys A., et al. Involvement of GAGs in the activity of proinflammatory factors. Adv Exp Med Biol 2003, 535:95-106.
7. American Diabetes Association Diabetic nephropathy. Diabetes Care 2003, 26(Suppl 1):S94-S98.
8. Aminoff M., Carter J.E., Chadwick R.B., et al. Mutations in CUBN, encoding the intrinsic factor-vitamin B12 receptor, cubilin, cause hereditary megaloblastic anaemia 1. Nat Genet 1999, 21:309-313.
9. Asanuma K., Mundel P. The role of podocytes in glomerular pathobiology. Clin Exp Nephrol 2003, 7:255-259.
10. Bakoush O., Tencer J., Torffvit O., et al. Increased glomerular albumin permeability in old spontaneously hypertensive rats. Nephrol Dial Transplant 2004, 19:1724-1731.
11. Ballmer P.E. Causes and mechanisms of hypoalbuminaemia. Clin Nutr 2001, 20:271-273.
12. Baricos W.H., Zhou Y., Fuerst R.S., et al. The role of aspartic and cysteine proteinases in albumin degradation by rat kidney cortical lysosomes. Arch Biochem Biophys 1987, 256:687-691.
13. Bariéty J., Druet P., Laliberté F., et al. Ultrastructural evidence, by immunoperoxidase technique, for a tubular reabsorption of endogenous albumin in normal rat. Lab Invest 1978, 38:175-180.
14. Bariéty J., Druet P., Laliberté F., et al. Ultrastructural evidence by immunohistochemical techniques for a tubular reabsorption of endogenous albumin and certain circulating protein in normal rat. Functional Ultrastructure of the Kidney 1980, 303-314. Academic, London, UK. A.B. Maunsbach, T.S. Olsen, E.I. Christensen (Eds.).
15. Bar-Or D., Lau E., Winkler J.V. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia- a preliminary report. J Emerg Med 2000, 19:311-315.
16. Bauer J., Berthold H., Schaefer F., et al. Quantification of conversion and degradation of circulating angiotensin in rats. Am J Physiol 1999, 277:R412-R418.
17. Bennett C.M., Glassock R.J., Chang R.L., et al. Permselectivity of the glomerular capillary wall. Studies of experimental glomerulonephritis in the rat using dextran sulfate. J Clin Invest 1976, 57:1287-1294.
18. Bent-Hansen L. Initial plasma disappearance and tissue uptake of 131I-albumin in normal rabbits. Microvasc Res 1991, 41:345-356.
19. Bernard A.C., Viau C., Ouled A., et al. Competition between low- and high-molecular-weight proteins for renal tubular uptake. Nephron 1987, 45:115-118.
20. Bertolatus J.A., Klinzman D. Macromolecular sieving of glomerular basement membrane in vitro: effect of polycation or biochemical modifications. Microvasc Res 1991, 41:311-327.
21. Bettelheim F.A., Laurent T.C., Pertoft H. Interaction between serum albumin and acidic polysaccharides. Carbohyd Res 1966, 2:391-402.
22. Bianchi S., Rigazzi R., Campese V.M. Microalbuminuria in essential hypertension: Significance, pathophysiology, and therapeutic implications. Am J Kidney Dis 1999, 34:973-995.
23. Bigazzi R., Bianchi S., Campese V.M., et al. Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. Nephron 1992, 61:94-97.
24. Bigazzi R., Bianchi S., Nenci R., et al. Increased thickness of the carotid artery in patients with essential hypertension and microalbuminuria. J Hum Hypertens 1995, 9:827-833.
25. Birn H., Fyfe J.C., Jacobsen C., et al. Cubilin is an albumin binding protein important for renal tubular albumin reabsorption. J Clin Invest 2000, 105:1353-1361.
26. Bliss D.J., Brewer D.B. Increased albumin and normal dextran clearances in protein-overload proteinuria in the rat. Clin Sci 1985, 69:321-326.
27. Blouch K., Deen W.M., Fauvel J.P., et al. Molecular configuration and glomerular size selectivity in healthy and nephrotic humans. Am J Physiol 1997, 273:F430-F437.
28. Bohrer M.P., Deen W.M., Robertson C.R., et al. Influence of molecular configuration on the passage of macromolecules across the glomerular capillary wall. J Gen Physiol 1979, 74:583-593.
29. Bohrer M.P., Deen W.M., Robertson C.R., et al. Mechanism of angiotensin II-induced proteinuria in the rat. Am J Physiol 1977, 233:F13-F21.
30. Bolton G.R., Deen W.M., Daniels B.S. Assessment of charge-selectivity of glomerular basement membrane using ficoll sulfate. Am J Physiol 1998, 274:F889-F896.
31. Borch-Johnsen K., Feldt-Rasmussen B., Strandgaard S., et al. Urinary albumin excretion an independent predictor of ischaemic heart disease. Arterioscler Thromb Vasc Biol 1999, 19:1992-1997.
32. Border W.A., Noble N.A. Evidence that TGF-β should be a therapeutic target in diabetic nephropathy. Kidney Int 1998, 54:1390-1391.
33. Boute N., Gribouval O., Roselli S., et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 2000, 24:349-354.
34. Braam B., Mitchell K.D., Fox J., et al. Proximal tubular secretion of angiotensin II in rats. Am J Physiol 1983, 264:F891-F898.
35. Bray J., Robinson G.B. Influence of charge on filtration across renal basement membrane films in vitro. Kidney Int 1984, 25:527-533.
36. Brinkman J.W., Bakker S.J., Gansevoort R.T., et al. Which method for quantifying urinary albumin excretion gives what outcome? A comparison of immunonephelometry with HPLC. Kidney Int 2004, (Suppl 92):S69-S75.
37. Broch H., Imerslund O., Monn E., et al. Imerslund-Gräsbeck anemia: a long-term follow-up study. Acta Paediatr Scand 1984, 73:248-253.
38. Brunskill N.J., Nahorski S., Walls J. Characterisation of albumin binding in opossum kidney cells and the identification of potential receptors. Pflugers Arch 1997, 433:497-504.
39. Buktenica S., Olenick S.J., Salgia R., et al. Degradation and regurgitation of extracellular proteins by cultured mouse peritoneal macrophages and baby hamster kidney fibroblasts. J Biol Chem 1987, 262:9469-9476.
40. Burne M.J., Osicka T.M., Comper W.D. Fractional clearance of high molecular weight proteins on conscious rats using a continuous infusion method. Kidney Int 1999, 55:261-270.
41. Burne M.J., Panagiotopoulos S., Jerums G., et al. Alterations in renal degradation of albumin in early experimental diabetes in the rat: a new factor in the mechanism of albuminuria. Clin Sci 1998, 95:67-72.
42. Burne M.J., Vyas S.V., Smit M.F., et al. Competition between polyanions in glomerular binding and renal clearance. Arch Biochem Biophys 1997, 340:257-264.
43. Calzada-Garcia J., González M.N.P., Benito-Andrés F.J., et al. Evaluation of patterns of urinary proteins by SDS-PAGE in rats of different ages. Mech Aging Dev 1996, 87:1-13.
44. Caulfield J.P., Farquhar M.G. The permeability of glomerular capillaries to graded dextrans. Identification of the basement membrane as the primary filtration barrier. J Cell Biol 1974, 63:883-903.
45. Caulfield J.P., Reid J.J., Farquhar M.G. Alterations of the glomerular epithelium in acute aminonucleoside nephrosis. Evidence for formation of occluding junctions and epithelial cell detachment. Lab Invest 1976, 34:43-59.
46. Cessac-Guillemet A.L., Mounier F., Borot C., et al. Characterisation and distribution of albumin binding protein in normal rat kidney. Am J Physiol 1996, 271:F101-F107.
47. Chander P.N., Gealekman O., Brodsky S.V., et al. Nephropathy in zucker diabetic fat rat is associated with oxidative and nitrosative stress: prevention by chronic therapy with a peroxynitrite scavenger ebsel. J Am Soc Nephrol 2004, 15:2391-2403.
48. Chang R.L.S., Deen W.M., Robertson C.R., et al. Permselectivity of the glomerular capillary wall, III: restricted transport of polyanions. Kidney Int 1975, 8:212-218.
49. Chang R.LS., Ueki I.F., Troy J.L., et al. Permselectivity of the glomerular capillary wall to macromolecules, II: experimental studies in rats using neutral dextrans. Biophys J 1975, 15:887-906.
50. Chaudhury C., Mehnaz S., Robinson J.M., et al. The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan. J Exp Med 2003, 197:315-322.
51. Christensen E.I., Rennke H.G., Carone F.A. Renal tubular uptake of protein: effect of molecular charge. Am J Physiol 1983, 244:F436-F441.
52. Christensen E.I. Rapid protein uptake and digestion in proximal tubule lysosomes. Kidney Int 1976, 10:301-310.
53. Ciarimboli G., Hjalmarsson C., Bökenkamp A., et al. Dynamic alterations of glomerular charge density in fixed rat kidneys suggest involvement of endothelial cell coat. Am J Physiol 2003, 285:F722-F730.
54. Clavant S.P., Comper W.D. Urinary clearance of albumin is critically determined by its tertiary structure. J Lab Clin Med 2003, 142:372-384.
55. Clavant S.P., Forbes J.M., Thallas V., et al. Reversible angiotensin II-mediated albuminuria in rat kidneys is dynamically associated with cytoskeletal organization. Nephron Physiol 2003, 93:51-60.
56. Clavant S.P., Greive K.A., Nikolovski J., et al. Albumin fragments in normal rat urine are derived from rapidly degraded filtered albumin. Nephrology 2003, 8:65-72.
57. Cojocel C., Maita K., Baumann K., et al. Renal processing of low molecular weight proteins. Pflügers Arch 1984, 401:333-339.
58. Comper W.D. The thermodynamic and hydrodynamic properties of macromolecules that influence the hydrodynamics of porous systems. J Theor Biol 1994, 168:421-427.
59. Comper W.D., Glasgow E.F. Charge selectivity in kidney ultrafiltration. Kidney Int 1995, 47:1242-1251.
60. Comper W.D., Osicka T.M., Clark M., et al. Earlier detection of microalbuminuria in diabetic patients using a new urinary albumin assay. Kidney Int 2004, 65:1850-1855.
61. Comper W.D., Tay M., Wells X., et al. Desulphation of dextran sulphate during kidney ultrafiltration. Biochem J 1994, 297:31-34.
62. Cooper M.E., Vranes D., Youssef S., et al. Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes 1999, 48:2229-2239.
63. Cui S., Verroust P.J., Moestrup S.K., et al. Megalin/gp330 mediates uptake of albumin in renal proximal tubule. Am J Physiol 1996, 271:F900-F907.
64. Curtis G.H., Gall D.G. Macromolecular transport by rat gastric mucosa. Am J Physiol 1992, 262:G1033-G1040.
65. D'Amico G., Bazzi C. Pathophysiology of proteinuria. Kidney Int 2003, 63:809-825.
66. +H exchanger 3 accumulates and is functional in recycling endosomes. J Biol Chem 1998, 273:2035-2045.
67. Dalle-Donne I., Giustarini D., Colombo R., et al. Protein carbonylation in human diseases. Trends Mol Med 2003, 9:169-176.
68. Daniels B.S. Increased albumin permeability in vitro following alterations of glomerular charge is mediated by the cells of the filtration barrier. J Lab Clin Med 1994, 124:224-230.
69. Davies D.J., Brewer D.B., Hardwicke J. Urinary proteins and glomerular morphometry in protein overload proteinuria. Lab Invest 1978, 38:232-243.
70. Davies R.W., Staprans I., Hutchinson F.N., et al. Proteinuria, not altered albumin metabolism, affect hyperlipidemia in the nephrotic rat. J Clin Invest 1990, 86:600-605.
71. Debigaré R., Price S.R. Proteolysis, the ubiquitin-proteasome system, and renal diseases. Am J Physiol 2003, 285:F1-F8.
72. Deckert T., Feldt-Rasmussen B., Borch-Johnsen K., et al. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989, 32:219-226.
73. Deckert T., Kofoed-Enevoldsen A., Vidal P., et al. Size and charge selectivity of glomerular filtration in type I (insulin dependent) diabetic patients with and without albuminuria. Diabetologia 1993, 36:244-251.
74. Deen W.M., Lazzara M.J., Myers B.D. Structural determinants of glomerular permeability. Am J Physiol 2001, 281:F579-F596.
75. Deen W.M., Ueki I.F., Brenner B.M. Permeability of renal peritubular capillaries to neutral dextrans and endogenous albumin. Am J Physiol 1976, 231:283-291.
76. Deferrari G., Repetto M., Calvi C., et al. Diabetic nephropathy from micro- to macroalbuminuria. Nephrol Dial Transplant 1998, 13:11-15.
77. Dinneen S.F., Gerstein H.C. The association of microalbuminuria and mortality in non-insulin dependent diabetes mellitus: A systematic overview of the literature. Arch Intern Med 1997, 157:1413-1418.
78. Dunn K.W., Sandoval R.M., Kelly K.J., et al. Functional studies of the kidney of living animals using multicolor two-photon microscopy. Am J Physiol 2002, 283:C905-C916.
79. Dustin M.L., Olszowy M.W., Holdorf A.D., et al. A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts. Cell 1998, 94:667-677.
80. Eddy A.A. Interstitial nephritis induced by protein-overload proteinuria. Am J Pathol 1989, 135:719-733.
81. Einsbach G.M., Van Liew J.B., Boylan J.W. Effect of angiotensin on the filtration of protein in the rat kidney: A micropuncture study. Kidney Int 1975, 8:80-87.
82. Emori T., Takahashi M., Sugiyama K., et al. Age-related changes in plasma proteins of analbuminemic rats. Exp Animals 1983, 32:123-132.
83. Eppel G.A., Nagy S., Jenkins M.A., et al. Variability of standard clinical protein assays in the analysis of a model urine solution of fragmented albumin. Clin Biochem 2000, 33:487-494.
84. Eppel G.A., Osicka T.M., Pratt L.M., et al. The return of glomerular filtered albumin to the rat renal vein. Kidney Int 1999, 55:1861-1870.
85. Eppel G.A., Pratt L.M., Greive K.A., et al. Exogenous albumin peptides influence the processing of albumin during renal passage. Nephron 2002, 92:156-164.
86. Eppel G.A., Takazoe K., Nikolic-Paterson D.J., et al. Characteristics of albumin processing during renal passage in anti-thy 1 and anti-glomerular basement membrane glomerulonephritis. Am J Kidney Dis 2000, 35:418-426.
87. Farshori P., Holzbaur E.L.F. Dynactin phosphorylation is modulated in response to cellular effectors. Biochem Biophys Res Comm 1997, 232:810-816.
88. Fisher S.E., Black G.C., Lloyd S.E., et al. Isolation and partial characterization of a chloride channel gene which is expressed in kidney and is a candidiate for Dent's disease (an X-linked hereditary. Hum Mol Genet 1994, 3:2053-2059.
89. Fisher S.E., van Bakel I., Lloyd S.E., et al. Cloning and characterization of CLCN5, the human kidney chloride channel gene implicated in Dent's disease (an X-linked hereditary nephrolithiasis). Genomics 1995, 29:598-606.
90. Forbes J.M., Bonnet F., Russo L.M., et al. Modulation of nephrin in the diabetic kidney: association with systemic hypertension and increasing albuminuria. J Hypertens 2002, 20:985-992.
91. Foster M.W., McMahon T.J., Stamler J.S. S-nitrosylation in health and disease. Trends Mol Med 2003, 9:160-168.
92. Fox J.G., Quin J.D., Paterson K.R., et al. Glomerular charge selectivity in type I (insulin-dependent) diabetes mellitus. Diabet Med 1995, 12:387-391.
93. Fried T.A., McCoy R.N., Osgood R.W., et al. Effect of albumin on glomerular ultrafiltration coefficient in isolated perfused dog glomerulus. Am J Physiol 1986, 250:F1119-F1122.
94. Fujimoto M., Maezawa Y., Yokote K., et al. Mice lacking Smad3 are protected against streptozotocin-induced diabetic nephropathy. Biochem Biophys Res Commun 2003, 305:1002-1007.
95. Furness P.N., Hall L.L., Shaw J.A., et al. Glomerular expression of nephrin is decreased in acquired human nephrotic syndrome. Nephrol Dial Transplant 1999, 14:1234-1237.
96. Galaske R.G., van Liew J., Feld L.G. Filtration and reabsorption of endogenous low-molecular weight protein in the rat kidney. Kidney Int 1979, 16:394-403.
97. Galazka V.B., Smith D., Ledward D.A., et al. Complexes of bovine serum albumin with sulphated polysaccharides: effects of pH, ionic strength and high pressure treatment. Food Chem 1999, 64:303-310.
98. Gall M-A., Rossing P., Kofoed-Enevoldsen A., et al. Glomerular size and charge selectivity in type 2 (non insulin-dependent) diabetic patients with diabetic nephropathy. Diabetologia 1994, 37:195-201.
99. Gandhi R.R., Bell D.R. Importance of charge on transvascular albumin transport in skin and skeletal muscle. Am J Physiol 1992, 262:H999-H1008.
100. Gekle M., Mildenberger S., Freudinger R., et al. Functional characterization of albumin binding to the apical membrane of OK cells. Am J Physiol 1996, 271:F286-F291.
101. Gekle M., Mildenberger S., Freudinger R., et al. Albumin endocytosis in OK cells: Dependence on actin and microtubules and regulation by protein kinases. Am J Physiol 1997, 41:668-677.
102. Gekle M. Renal tubule albumin transport. Annu Rev Physiol 2004, 67:12.1-12.22.
103. Gerber B.R., Schubert M. The exclusion of large solutes by cartilage protein polysaccharide. Biopolymers 1964, 2:259-273.
104. Gerlofs-Nijland M.E., Assmann K.J., Dijkman H.B., et al. Albuminuria in mice after injection of antibodies against aminopeptidase A: role of angiotensin II. J Am Soc Nephrol 2001, 12:2711-2720.
105. Gerstein H.C., Mann J.F., Pogue J., et al. Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. Diabetes Care 2000, 23(Suppl 2):B35-B39.
106. Gerstein H.C., Mann J.F., Yi Q., Zinman B., et al. Albuminuria and risk of cardiovascular events, death and heart failure in diabetic and nondiabetic individuals. J Am Med Assoc 2001, 286:421-426.
107. Ghitescu L., Bendayan M. Transendothelial transport of serum albumin: a quantitative immunocytochemical study. J Cell Biol 1992, 117:745-755.
108. Ghitescu L., Fixman A., Simionescu M., et al. Specific binding sites for albumin restricted to plasmalemmal vesicles of continuous capillary endothelium: receptor-mediated transcytosis. J Cell Biol 1986, 102:1304-1311.
109. Gilbert R.E., Wu L.L., Kelly D.J., et al. Pathological expression on renin and angiotensin II in the renal tubule after subtotal nephrectomy: implications for the pathogenesis of tubulointerstitial fi. Am J Pathol 1999, 155:429-440.
110. Grandi A.M., Santillo R., Zanzi P., et al. Microalbuminuria in never-treated hypertensives: lack of relationship to hyperinsulinemia and genetic pre-disposition to hypertension. Am J Hypertens 2000, 13:353-358.
111. Gräsbeck R., Gordin R., Kantero I., et al. Selective vitamin B12 malabsorption and proteinuria in young people: a syndrome. Acta Med Scand 1960, 167:289-296.
112. Greive K.A., Balazs N.D., Comper W.D. Protein fragments in urine have been considerably underestimated by various protein assays. Clin Chem 2001, 47:1717-1719.
113. Greive K.A., Eppel G.A., Reeve S., et al. Immuno-unreactive albumin excretion increases in streptozotocin diabetic rats. Am J Kidney Dis 2001, 38:144-152.
114. Greive K.A., Nikolic-Paterson D.J., Guimaraes M.A.M., et al. Glomerular permselectivity factors are not responsible for the increase in fractional clearance of albumin in rat glomerulonephritis. Am J Pathol 2001, 159:1159-1170.
115. Greive K.A., Osicka T.M., Russo L.M., et al. Nephrotic-like proteinuria in experimental diabetes. Am J Nephrol 2003, 23:38-46.
116. Groggel G.C., Stevenson J., Hovingh P., et al. Changes in heparan sulfate correlate with increased glomerular permeability. Kidney Int 1988, 33:517-523.
117. Gschwend S., Pinto-Sietsma S.J., Buikema H., et al. Impaired coronary endothelial function in a rat model of spontaneous albuminuria. Kidney Int 2002, 62:181-191.
118. Guasch A., Myers B.D. Determinants of glomerular hypofiltration in nephrotic patients with minimal change nephropathy. J Am Soc Nephrol 1994, 4:1571-1581.
119. Gudehithlu K.P., Pegoraro A.A., Dunea G., et al. Degradation of albumin by the renal proximal tubule cells and the subsequent fate of its fragments. Kidney Int 2004, 65:2113-2122.
120. Guimarães M.A.M., Nikolovski J., Pratt L.M., et al. Anomalous fractional clearance of negatively charged Ficoll relative to uncharged Ficoll. Am J Physiol 2003, 285:F1118-F1124.
121. Haas M., de Zeeuw D., van Zanten A., et al. Quantification of renal low-molecular-weight protein handling in the intact rat. Kidney Int 1993, 43:949-954.
122. Hallberg P., Lind L., Billberger K., et al. Transforming growth factor beta1 genotype and change in left ventricular mass during antihypertensive treatment-Results from the Swedish Irbesatan Left Ventricular Hypertrophy Investigation versu Atenolol (SILVHIA). Clin Cardiol 2004, 27:169-173.
123. Hallman N., Hjelt L., Ahvenainen E.K. Nephrotic syndrome in newborn and young infants. Ann Pediatr Fenn 1956, 2:227-241.
124. Haraldsson B., Sörensson J. Why do we not all have proteinuria? An update of our current understanding of the glomerular barrier. News Physiol Sci 2004, 19:7-10.
125. Hardin J.A., Kimm M.H., Wirasinghe M., et al. Macromolecular transport across the rabbit proximal and distal colon. Gut 1999, 44:218-225.
126. Harris R.C., Akai Y., Yasuda T., et al. The role of physical forces in alterations of mesangial cell function. Kidney Int 1994, 45:S17-S21.
127. Harris R.C., Haraldsson M.A., Badr K.F. Continuous stretch-relaxation in culture alters rat mesangial cell morphology, growth characteristics and metabolic activity. Lab Invest 1992, 66:548-554.
128. Hilliard L.M., Osicka T.M., Clavant S., et al. Characterisation of the urinary albumin degradation pathway in the isolated perfused rat kidney. J Lab Clin Med 2006, 147:36-44.
129. Hillege H.L., Fidler V., Diercks G.F., et al. Prevention of renal and vascular end stage disease (PREVEND) study group: Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002, 106:1777-1782.
130. Hillege H.L., Janssen W.M., Bak A.A., et al. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med 2001, 249:519-526.
131. Hirakata M., Kaname S., Chung U.G., et al. Tyrosine kinase dependent expression of TGF-β induced by stretch in mesangial cells. Kidney Int 1997, 51:1028-1036.
132. Hjalmarsson C., Johansson B.R., Haraldsson B. Electron microscopic evaluation of the endothelial surface layer of glomerular capillaries. Microvasc Res 2004, 67:9-17.
133. Houlihan C.A., Akdeniz A., Tsalamandris C., et al. Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate: effects of angiotensin receptor blockade and sodium restriction. Diabetes Care 2002, 25:1072-1077.
134. Hryciw D.H., Ekberg J., Lee A., et al. Ned4-2 functionally interacts with C1C-5: involvement in constitutive albumin endocytosis in proximal tubule cells. J Biol Chem 2004, 279:54996-55007.
135. Huber T.B., Kottgen M., Schilling B., et al. Interaction with podocin facilitates nephrin signalling. J Biol Chem 2001, 276:41543-41546.
136. Huh W., Kim D.J., Kim M.K., et al. Expression of nephrin in acquired human glomerular disease. Nephrol Dial Transplant 2002, 17:478-484.
137. Hysing J., Tolleshaug H., Curthoys N.P. Reabsorption and intracellular transport of cytochrome c and lysozyme in rat kidney. Acta Physiol Scand 1990, 140:419-427.
138. Hysing J., Tolleshaug H. Quantitative aspects of the uptake and degradation of lysozyme in the rat kidney in vivo. Biochim Biophys Acta 1986, 887:42-50.
139. Iglesias J., Abernethy V.E., Wang Z., et al. Albumin is a major serum survival factor for renal tubular cells and macrophages through scavenging of ROS. Am J Physiol 1999, 277:F711-F722.
140. Inoue T., Yaoita E., Kurihara H., et al. FAT is a component of glomerular slit diaphragms. Kidney Int 2001, 59:1003-1012.
141. Isenman L.D., Dice J.F. Secretion of intact proteins and peptide fragments by lysosomal pathways of protein degradation. J Biol Chem 1989, 264:21591-21596.
142. Isenman L.D., Dice J.F. Selective release of peptides from lysosomes. J Biol Chem 1993, 268:23856-23859.
143. Jeansson M., Haraldsson B. Glomerular size and charge selectivity in the mouse after exposure to glucosaminglycan-degrading enzymes. J Am Soc Nephrol 2003, 14:1756-1765.
144. Jensen J.S., Feldt-Rasmussen B., Strandgaard S., et al. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension 2000, 35:898-903.
145. Johnson E.M., Berk D.A., Jain R.K., et al. Diffusion and partitioning of proteins in charged agarose gels. Biophys J 1995, 68:1561-1568.
146. Johnson E.M., Deen W.M. Electrostatic effects on the equilibrium partitioning of spherical colloids in random fibrous media. J Coll Int Sci 1996, 178:749-756.
147. Johnson V., Maack T. Renal extraction, filtration, absorption, and catabolism of growth hormone. Am J Physiol 1977, 233:F185-F196.
148. Joles J.A., Bijleveld C., van Tol A., et al. Plasma triglyceride levels are higher in nephrotic than in analbuminemic rats despite a similar increase in hepatic triglyceride secretion. Kidney Int 1995, 47:566-572.
149. Joles J.A., Van Goor H., Van Der Horst M.L., et al. High lipid levels in very low density lipoprotein and intermediate density lipoprotein may cause proteinuria and glomerulosclerosis in aging female analbuminemic rats. Lab Invest 1995, 73:912-921.
150. Kagami S., Border W.A., Miller D.E., et al. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 1994, 93:2431-2437.
151. Kanwar Y.S., Linker A., Farquhar M.G. Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion. J Cell Biol 1980, 86:688-693.
152. Kanwar Y.S., Liu Z.Z., Kashihara N., et al. Current status of the structural and functional basis of glomerular filtration and proteinuria. Semin Nephrol 1991, 11:390-413.
153. Kaplan J.M., Kim S.H., North K.N., et al. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 2000, 24:251-256.
154. + exchanger stably expressed in chinese hamster ovary cells. J Biol Chem 1994, 269:23544-23552.
155. Katz J., Rosenfeld S., Sellers A.L. Role of the kidney in plasma albumin catabolism. Am J Physiol 1960, 198:814-818.
156. Katz J., Rosenfeld S., Sellers A.L. Sites of plasma albumin catabolism in the rat. Am J Physiol 1961, 200:1301-1306.
157. Kawachi H., Koike H., Kurihara H., et al. Cloning of rat nephrin: expression in developing glomeruli and in proteinuric states. Kidney Int 2000, 57:1949-1961.
158. Kawachi H., Kurihara H., Topham P.S., et al. Slit diaphragm-reactive nephritogenic MAb 5-1-6 alters expression of ZO-1 in rat podocytes. Am J Physiol 1997, 273:F984-F993.
159. Kaysen G.A., Kirkpatrick W.G., Couser W.G. Albumin homeostasis in the nephrotic rat: nutritional considerations. Am J Physiol 1984, 247:F192-F202.
160. Kaysen G.A., Watson J.B. Mechanism of hypoalbuminemia in the 7/8-nephrectomised rat with chronic renal failure. Am J Physiol 1982, 243:F372-F378.
161. Keane W.F. Proteinuria: Its clinical importance and role in progressive renal disease. Am J Kidney Dis 2001, 35(Suppl 1):S97-S105.
162. Kelly D.J., Aaltonen P., Cox A.J., et al. Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: differing effects of anti-proteinuric therapies. Nephrol Dial Transplant 2002, 17:1327-1332.
163. Kelly D.J., Gilbert R.E., Cox A.J., et al. Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy. J Am Soc Nephrol 2001, 12:2098-2107.
164. Kestilä M., Lenkkeri U., Männikö M., et al. Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol Cell 1998, 1:575-582.
165. Kestilä M., Männikö M., Holmberg C., et al. Congenital nephrotic syndrome of the Finnish type maps to the long arm of chromosome 19. Am J Hum Genet 1994, 54:757-764.
166. Koltun M., Comper W.D. Retention of albumin in the circulation is governed by saturable renal cell-mediated processes. Microcirculation 2004, 11:351-360.
167. Koltun M., Nikolovski J., Strong K., et al. Mechanism of hypoalbuminemia in rodents. Am J Physiol 2005, 288:H1604-H1610.
168. Koya D., King G.L. Protein kinase C activation and the development of diabetic complications. Diabetes 1998, 47:859-866.
169. Koziell A., Iyer V.K., Moghul N.E., et al. Congenital nephrotic syndrome. Pediatr Nephrol 2001, 16:185-189.
170. Kriz W. Podocyte is the major culprit accounting for the progression of chronic renal disease. Microsc Res Tech 2002, 57:189-195.
171. Kurtz A., Pfeilschifter J., Hutter A., et al. Role of protein kinase C in inhibition of renin released by vasoconstrictors. Am J Physiol 1986, 250:C563-C571.
172. Lahdenkari A-T., Lounatmaa K., Patrakka J., et al. Podocytes are firmly attached to glomerular basement membrane in kidneys with heavy proteinuria. J Am Soc Nephrol 2004, 15:2611-2618.
173. Landwehr D.M., Carvalho J.S., Oken D.E. Micropuncture studies of the filtration and absorption of albumin by nephrotic rats. Kidney Int 1977, 11:9-17.
174. Lane J.T. Microalbuminuria as a marker of cardiovascular and renal risk in type 2 diabetes mellitus: a temporal perspective. Am J Physiol 2004, 286:F442-F450.
175. Lapinski R., Perico N., Remuzzi A., et al. Angiotensin II modulates glomerular capillary permselectivity in rat isolated perfused kidney. J Am Soc Nephrol 1996, 7:653-660.
176. Laurent T.C., Björk I., Pietruszkiewicz A., et al. On the interaction between polysaccharides and other macromolecules. II: The transport of globular particles through hyaluronic acid solutions. Biochim Biophys Acta 1963, 78:351-359.
177. Laurent T.C. The interaction between polysaccharides and other macromolecules, 9: the exclusion of molecules from hyaluronic acid gels and solutions. Biochem J 1964, 93:106-112.
178. Leheste J.R., Rolinski B., Vorum H., et al. Megalin knockout mice as an animal model of low molecular weight proteinuria. Am J Pathol 1999, 155:1361-1370.
179. Lemley K.V. Glomerular size selectivity during protein overload in the rat. Am J Physiol 1993, 264:F1046-F1051.
180. Lencer W.I., Weyer P., Verkman A.S., et al. FITC-dextran as a probe for endosome function and localization in kidney. Am J Physiol 1990, 258:C309-C317.
181. Levidiotis V., Freeman C., Tikellis C., et al. Heparanase is involved in the pathogenesis of proteinuria as a result of glomerulonephritis. J Am Soc Nephrol 2004, 15:68-78.
182. Lewy J.E., Pesce A. Micropuncture study of albumin transfer in aminonucleoside nephrosis in the rat. Pediatr Res 1973, 7:553-559.
183. Li Q., Muragaki Y., Hatamura I., et al. Stretch-induced collagen synthesis in cultured smooth muscle cells from rabbit aortic media and a possible involvement of angiotensin II and TGF-β. J Vasc Res 1998, 35:93-103.
184. Lloyd S.E., Pearce S.H., Fisher S.E., et al. A common molecular basis for three inherited kidney stone diseases. Nature 1996, 379:445-449.
185. Loon N., Shemesh O., Morelli E., et al. Effect of angiotensin II infusion on the human glomerular filtration barrier. Am J Physiol 1989, 257:F608-F614.
186. Lou M.F., Hamilton P.B. Separation and quantitation of peptides and amino acids in normal human urine. Meth Bioch Anal 1979, 25:203-271.
187. Luimula P., Sandstrom N., Novikov D., et al. Podocyte-associated molecules in puromycin aminonucleoside nephrosis of the rat. Lab Invest 2002, 82:713-718.
188. Luton F., Cardone M.H., Zhang M., et al. Role of tyrosine phosphorylation in ligand-induced regulation of trancytosis of the polymeric Ig receptor. Mol Biol Cell 1998, 9:1787-1802.
189. Maack T., Johnson V., Kau S.T., et al. Renal filtration, transport, and metabolism of lowmolecular weight proteins: A review. Kidney Int 1979, 16:251-270.
190. Maack T., MacKensie D.D.S., Kinter W.B. Intracellular pathways of renal reabsorption of lysozyme. Am J Physiol 1971, 221:1609-1616.
191. Maack T., Park C.H., Camargo M.J.F. Renal filtration, transport and metabolism of proteins. The Kidney: Physiology and Pathophysiology 1992, 3005-3038. Raven Press, New York. 3rd ed. D.W. Seldin, G. Giebisch (Eds.).
192. Maack T. Renal handling of low molecular weight proteins. Am J Med 1975, 58:57-64.
193. Macconi D., Ghilardi M., Bonassi M.E., et al. Effect of angiotensin-converting enzyme inhibition on glomerular basement membrane permeability and distribution of zonula occludens-1 in MWF rats. J Am Soc Nephrol 2000, 11:477-489.
194. Maddox D.A., Deen W.M., Brenner B.M. Glomerular filtration. Handbook of physiology, Section 8, Renal Physiology 1992, 545-638. Oxford University Press, New York. E.E. Windhager (Ed.).
195. Mann G.E. Alterations of myocardial capillary permeability by albumin in the isolated, perfused rabbit heart. J Physiol (Lond) 1981, 319:311-323.
196. Männikö M., Kestilä M. Fine mapping and haplotype analysis of the locus for congenital nephrotic syndrome on chromosome 19q13.1. Am J Hum Genet 1995, 57:1377-1383.
197. Marino M., Andrews D., Brown D., et al. Transcytosis of retinol-binding protein across renal proximal tubule cells after megalin (gp 330)-mediated endocytosis. J Am Soc Nephrol 2001, 12:637-648.
198. Maroudas A., Schneiderman R., Popper O. The role of water, proteoglycan, and collagen in solute transport in cartilage. Articular Cartilage and Osteoarthritis 1991, 355-391. Raven Press, New York. K.E. Kuettner, R. Schleyerbach, J.G. Peyron, V.C. Hascall (Eds.).
199. Maroudas A. Physicochemical properties of articular cartilage. Adult Articular Cartilage 1979, 131-170. Pitman, London. 2nd ed. M.A.R. Freeman (Ed.).
200. Marshall S.M., Alberti K.G. Comparison of the prevalence and associated features of abnormal albumin excretion in insulin-dependent and non-insulin-dependent diabetes. Q J Med 1989, 70:61-71.
201. Marshall S.M. Blood pressure control, microalbuminuria and cardiovascular risk in type 2 diabetes mellitus. Diabet Med 1999, 16:358-372.
202. Marshansky V., Ausiello D.A., Brown D. Physiological importance of endosomal acidification: potential role in proximal tubulopathies. Curr Opin Nephrol Hypertens 2002, 11:527-537.
203. Marshansky V., Vinay P. Proton gradient formation in early endosomes from proximal tubules. Biochim Biophys Acta 1996, 1284:171-180.
204. Mason J.C., Curry F.E., Michel C.C. The effects of proteins upon the filtration coefficient of individually perfused frog mesenteric capillaries. Microvasc Res 1977, 13:185-202.
205. Maunsbach A.B. Adsorption of 125I-labeled homologous albumin by rat kidney proximal cells: a study of microperfused single proximal tubules by electron microscopic autoradiography and histochemistry. J Ultrastruct Res 1966, 15:197-241.
206. McCurdy T.R., Gataiance S., Eltringham-Smith L.J., et al. A covalently linked recombinant albumin dimer is more rapidly cleared in vivo than are wild-type and mutant C34A albumin. J Lab Clin Med 2004, 143:115-124.
207. McQueen M.J., Gerstein H.C., Pogue J., et al. Reevaluation by high-performance liquid chromatography: clinical significance of microalbuminuria in individuals at high-risk of cardiovascular disease in th Outcomes Prevention Evaluation (HOPE) Study. Am J Kidney Dis 2006, 48:889-896.
208. Mentzel S., Assmann K.J.M., Dijkman H.B.P.M., et al. Inhibition of aminopeptidase A activity causes an acute albuminuria in mice: an Angiotensin II-mediated effect?. Nephrol Dial Transplant 1996, 11:2163-2169.
209. Mentzel S., Van Son J.P.H.F., Dijkman H.B.P.M., et al. Induction of albuminuria in mice: synergistic effect of two monoclonal antibodies directed to different domains of aminopeptidase A. Kidney Int 1999, 55:1335-1347.
210. Meyer F.A. Macromolecular basis of globular protein exclusion and of swelling pressure in loose connective tissue (umbilical cord). Biochim Biophys Acta 1983, 755:388-399.
211. Michel C.C., Curry F.E. Microvascular permeability. Physiol Rev 1999, 79:703-761.
212. Moestrup S.K., Verroust P.J. Megalin- and cubilin-mediated endocytosis of protein-bound vitamins, lipids, and hormones in polarized epithelia. Annu Rev Nutr 2001, 21:407-428.
213. Mogensen C.E. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984, 310:356-360.
214. Mohammad-Pannah R., Harrison R., Dhani S., et al. The chloride channel ClC-4 contributes to endosomal acidification and trafficking. J Biol Chem 2003, 278:29267-29277.
215. Morita H., Yoshimura A., Inui K., et al. Heparan sulfate of perlecan is involved in glomerular filtration. J Am Soc Nephrol 2005, 16:1703-1710.
216. Myers B.D., Winetz J.A., Chui F., et al. Mechanisms of proteinuria in diabetic nephropathy: A study of glomerular barrier function. Kidney Int 1982, 21:633-641.
217. Myers, B.D., Okarma T.B., Friedman S., et al. Mechanisms of proteinuria in human glomerulonephritis. J Clin Invest 1982, 70:732-746.
218. Nakayama K., Natori Y., Sato T., et al. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis. J Lab Clin Med 2004, 143:106-114.
219. Navar L.G., Harrison-Bernard L.M., Wang C., et al. Concentrations and actions of intraluminal angiotensin II. J Am Soc Nephrol 1999, 10:S189-S195.
220. Neuhaus O.W. Renal reabsorption of low molecular weight proteins in adult male rats:? 2u-globulin. Proc Soc Exp Biol Med 1986, 182:531-539.
221. Nikolic-Paterson D.J., Hurst L.A., Comper W.D. Variable toxicity of dyes used in micropuncture studies. Nephrology 2001, 6:221-222.
222. Norden A.G., Lapsley M., Lee P.J., et al. Glomerular protein sieving and implications for renal failure in Fanconi syndrome. Kidney Int 2001, 60:1885-1892.
223. Norden A.G.W., Sharrat P., Cutillas P.R., et al. Quantitiative amino acid analysis and proteomic analysis: Very low excretion of polypeptides > 750 Da in normal urine. Kidney Int 2004, 66:1994-2003.
224. Nykjaer A., Dragun D., Walther D., et al. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 1999, 96:507-515.
225. Obermüller N., Kränzlin B., Blum W.F., et al. An endocytosis defect as a possible cause of proteinuria in polycystic kidney disease. Am J Physiol 2001, 280:F244-F253.
226. Ogston A.G., Preston B.N. The exclusion of protein by hyaluronic acid. J Biol Chem 1966, 241:17-19.
227. Ogston A.G., Preston B.N., Wells J.D. On the transport of compact particles through solutions of chain-polymers. Proc R Soc Lond A 1973, 333:297-316.
228. Ohlson M., Sörensson J., Haraldsson B. Glomerular size and charge selectivity in the rat as revealed by FITCFicoll and albumin. Am J Physiol 2000, 279:F84-F91.
229. Ohlson M., Sörensson J., Lindström K., et al. Effects of filtration rate on the glomerular barrier and clearance of four differently shaped molecules. Am J Physiol 2001, 281:F103-F113.
230. Oken D.E., Flamebaum W. Micropuncture studies of proximal tubule albumin concentration in normal and nephrotic rats. J Clin Invest 1971, 50:1498-1505.
231. Olbricht C.J., Geissinger B. Renal hypertrophy in STZ diabetic rats: role of proteolytic lysosomal enzymes. Kidney Int 1992, 41:966-972.
232. Oliver J.D., Anderson S., Troy J.L., et al. Determination of glomerular size-selectivity in the normal rat with Ficoll. J Am Soc Nephrol 1992, 3:214-228.
233. Olson J.L., Hostetter T.H., Rennke H.G., et al. Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. Kidney Int 1982, 22:112-126.
234. Olson J.L., Rennke H.G., Venkatachalam M.A. Alterations in the charge and size selectivity barrier of the glomerular filter in aminonucleoside nephrosis in rats. Lab Invest 1981, 44:271-279.
235. Öqvist B.W., Rippe A., Tencer J., et al. In vivo microvascular clearance of albumin in renal and extrarenal tissues in puromycin aminonucleoside (PAN) induced nephrotic syndrome. Nephrol Dial Transplant 1999, 14:1898-1903.
236. Orikasa M., Matsui K., Oite T., et al. Massive proteinuria induced in rats by a single intravenous injection of a monoclonal antibody. J Immunol 1988, 141:807-814.
237. Osicka T.M., Comper W.D. Characterization of immuno-unreactive urinary albumin. Clin Chem 2004, 50:2286-2291.
238. Osicka T.M., Comper W.D. Glomerular charge selectivity for anionic and neutral horseradish peroxidase. Kidney Int 1995, 47:1630-1637.
239. Osicka T.M., Comper W.D. Protein degradation during renal passage in normal kidneys is inhibited in experimental albuminuria. Clin Sci 1997, 93:65-72.
240. Osicka T.M., Comper W.D. Tubular inhibition destroys charge selectivity for anionic and neutral horseradish peroxidase. Biochim Biophys Acta 1998, 1381:170-178.
241. Osicka T.M., Forbes J.M., Thallas V., et al. Ramipril prevents microtubular changes in proximal tubules from streptozotocin diabetic rats. Nephrology 2003, 8:205-211.
242. Osicka T.M., Hankin A.R., Comper W.D. Puromycin aminonucleoside nephrosis results in a marked increase in fractional clearance of albumin. Am J Physiol 1999, 277:F139-F145.
243. Osicka T.M., Houlihan C.A., Chan J.G., et al. Albuminuria in patients with type 1 diabetes is directly linked to changes in the lysosome-mediated degradation of albumin during renal passage. Diabetes 2000, 49:1579-1584.
244. Osicka T.M., Kiriazis Z., Pratt L.M., et al. Ramipril and aminoguanidine restore lysosomal processing in streptozotocin diabetic rats. Diabetologia 2001, 44:230-236.
245. Osicka T.M., Panagiotopoulos S., Jerums G., et al. Fractional clearance of albumin is influenced by its degradation during renal passage. Clin Sci 1997, 93:557-564.
246. Osicka T.M., Pratt L.M., Comper W.D. Glomerular capillary wall permeability to albumin and horseradish peroxidase. Nephrology 1996, 2:199-212.
247. Osicka T.M., Russo L.M., Qiu M.-L., et al. Additive effects of hypertension and diabetes on renal cortical expression of PKC-α and -ε and α-tubulin but not PKC-β 1 and -β 2. J Hypertens 2003, 21:2399-2407.
248. Osicka T.M., Strong K.J., Nikolic-Paterson D.J., et al. Renal processing of serum proteins in an albumin-deficient environment: an in vivo study of glomerulonephritis in the Nagase analbuminaemic rat. Nephrol Dial Transplant 2004, 19:320-328.
249. Osicka T.M., Yu Y., Panagiotopoulos S., et al. Prevention of albuminuria by aminoguanidine or ramipril in STZ-diabetic rats is associated with the normalisation of renal protein kinase C. Diabetes 2000, 49:87-93.
250. Pagtalunan M.E., Miller P.L., Jumping-Eagle S., et al. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 1997, 99:342-348.
251. Palatini P., Graniero G.R., Canali C., et al. Relationship between albumin excretion rate, ambulatory blood pressue and left ventricular hypertrophy in mild hypertension. J Hypertens 1995, 13:1796-1800.
252. Park C.H., Maack T. Albumin absorption and catabolism by isolated perfused proximal convoluted tubules of the rabbit. J Clin Invest 1984, 73:767-777.
253. Pavenstädt H., Kriz W., Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev 2002, 83:253-307.
254. Pedrinelli R., Giamietro O., Carmassi F., et al. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994, 344:14-18.
255. Pegoraro A.A., Gudehithlu K.P., Cabrera E., et al. Handling of low-density lipoprotein by the renal tubule: release of fragments due to incomplete degradation. J Lab Clin Med 2002, 139:372-378.
256. Peters T. All about Albumin: Biochemistry, Genetics and Medical Applications 1996, Academic Press, San Diego.
257. Pisoni R., Ruggenenti P., Sangalli F., et al. Effect of high dose ramipril with or without indomethacin on glomerular selectivity. Kidney Int 2002, 62:1010-1019.
258. Pontremoli R., Sofia A., Ravera M., et al. Prevalence and clinical correlates of microalbuminura in essential hypertension: the MAGIC study, microalbuminuria: a genoa investigation on complications. Hypertension 1997, 30:1135-1143.
259. Prinsen B.H., de Sain-van der Velden M.G. Albumin turnover: experimental approach and its application in health and renal diseases. Clin Chim Acta 2004, 347:1-14.
260. Putaala H., Sainio K., Sariola H., et al. Primary structure of mouse and rat nephrin cDNA and structure and expression of the mouse gene. J Am Soc Nephrol 2000, 11:991-1001.
261. Qi W., Twigg S., Chen X., et al. Integrated actions of transforming growth factor-beta1 and connective tissue growth factor in renal fibrosis. Am J Physiol 2005, 288:F800-F809.
262. Quick M.W., Corey J.L., Davidson N., et al. Second messengers, trafficking related proteins, and amino acid residues that contribute to the functional regulation of the rat brain GABA transporter GAT1. J Neurosci 1997, 17:2967-2979.
263. Raats C.J.I., van den Born J., Berden J.H.M. Glomerular heparan sulfate alterations: mechanisms and relevance for proteinuria. Kidney Int 2000, 57:385-400.
264. Rabkin R., Fervenza F.C. Renal hypertrophy and kidney disease in diabetes. Diabetes Metab Rev 1996, 12:217-241.
265. Rantanen M., Palmen T., Patari A., et al. Nephrin TRAP mice lack slit diaphragms and show fibrotic glomeruli and cystic tubular lesions. J Am Soc Nephrol 2002, 13:1586-1594.
266. Recio F., Villamil F. Charge selectivity and urine amylase isoenzymes. Kidney Int 1994, (suppl 47):S89-S92.
267. Redon J., Liao Y., Lozano J.V., et al. Ambulatory blood pressure and microalbuminuria in essential hypertension: role of circadian variability. J Hypertens 1994, 12:947-953.
268. Reiser J., Kriz W., Kretzler M., et al. The glomerular slit diaphragm is a modified adherens junction. J Am Soc Nephrol 2000, 11:1-8.
269. Reiser J., Oh J., Shirato I. Podocyte migration during nephrotic syndrome requires a coordinated interplay between cathepsin L and α 3 integrin. J Biol Chem 2004, 279:34827-34832.
270. Reiser J., Von Gersdoff G., Loos M., et al. Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest 2004, 113:1390-1397.
271. Rennke H.G., Cotran R.S., Venkatachalam M.A. Role of molecular charge in glomerular permeability: tracer studies with cationized ferritins. J Cell Biol 1975, 67:638-646.
272. Rennke H.G., Patel Y., Venkatachalam M.A. Glomerular filtration of proteins: clearance of anionic, neutral, and cationic horseradish peroxidase in the rat. Kidney Int 1978, 13:278-288.
273. Rennke H.G., Venkatachalam M.A. Glomerular permeability of macromolecules: effect of molecular configuration on the fractional clearance of uncharged dextran and neutral horseradish peroxida. J Clin Invest 1979, 63:713-717.
274. Rennke H.G., Venkatachalam M.A. Glomerular permeability: in vivo tracer studies with polyanionic and polycationic ferritins. Kidney Int 1977, 11:44-53.
275. Riser B.L., Cortes P., Heilig C., et al. Cyclic stretching forces selectively upregulates TGF-β isoforms in cultured rat mesangial cells. Am J Pathol 1996, 148:1915-1923.
276. Romundstad S., Holmen J., Kvenild K., et al. Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals a 4.4-year follow-up study. Am J Kidney Dis 2003, 42:466-473.
277. Rops A.L.W.M.M., van der Vlag J., Lensen J.F.M., et al. Heparan sulfate proteoglycans in glomerular inflammation. Kidney Int 2004, 65:768-785.
278. Rosengren B-I., Rayyes O.A., Rippe B. Transendothelial transport of low-density lipoprotein and albumin across the rat peritoneum in vivo: Effects of the transcytosis inhibitors NEM and filipin. J Vasc Res 2002, 39:230-237.
279. 125I-bovine serum albumin. Lab Invest 1982, 47:177-184.
280. Rossa T.T., Palatini P. Clinical value of microalbuminuria in hypertension. J Hypertens 2000, 18:645-654.
281. Rossi M., Morita H., Sormunen R., et al. Heparan sulfate chains of perlecan are indispensable in the lens capsule but not the kidney. EMBO J 2003, 22:236-245.
282. Ruggenenti P., Mosconi L., Sangalli F., et al. Glomerular size selective dysfunction in NIDDM is not ameliorated by ACE inhibition or by calcium channel blockade. Kidney Int 1999, 55:984-994.
283. Ruggenenti P., Mosconi L., Vendramin G., et al. ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome. Am J Kidney Dis 2000, 35:381-391.
284. Ruotsalainen V., Ljungberg P., Wartinovaara J., et al. Nephrin is specifically located at the site of the slit diaphragm of glomerular podocytes. Proc Natl Acad Sci U S A 1999, 96:7962-7967.
285. Russo L.M., Bakris G., Comper W.D. Renal handling of albumin. A critical review of basic concepts and perspective. Am J Kid Dis 2002, 39:899-919.
286. Russo L.M., Brammar G.C., Jerums G., et al. The effect of ramipril on albumin excretion in diabetes and hypertension: the role of increased lysosomal activity and decreased transforming growth factor-. J Hypertens 2003, 21:419-428.
287. Russo L.M., Comper W.D., Osicka T.M. Mechanism of albuminuria associated with cardiovascular disease and kidney disease. Kidney Int 2004, (Suppl 92):S67-S68.
288. Russo L.M., Osicka T.M., Bonnet F., et al. Albuminuria in hypertension is linked to altered lysosomal activity and TGF-β1 expression. Hypertension 2002, 39:281-286.
289. Russo L.M., Osicka T.M., Brammar G.C., et al. Renal processing of albumin in diabetes and hypertension in rats. Am J Nephrol 2003, 23:61-70.
290. Russo L.M., Sandoval R.M., McKee M., et al. The normal kidney filters nephrotic levels of albumin retrieved by the proximal tubule cells: Retrieval is disrupted in nephrotic states. Kidney Int 2007, 71:504-513.
291. Ryan G.B., Karnovsky M.J. Distribution of endogenous albumin in the rat glomerulus: Role of hemodynamic factors in glomerular barrier function. Kidney Int 1976, 9:36-45.
292. Sandoval R.M., Kennedy M.D., Low P.S., et al. Uptake and trafficking of fluorescent conjugates of folic acid in intact kidney determined using intravital two-photon microscopy. Am J Physiol 2004, 287:C517-C526.
293. Scandling J.D., Black V.M., Deen W.M., et al. Glomerular permselectivity in healthy and nephrotic humans. Adv Nephrol 1992, 21:159-176.
294. Scandling J.D., Myers B.D. Glomerular size-selectivity and microalbuminuria in early diabetic glomerular disease. Kidney Int 1992, 41:840-846.
295. Schaefer L., Schaefer R.M., Ling H., et al. Renal proteinases and kidney hypertrophy in experimental diabetes. Diabetologia 1994, 37:567-571.
296. Schaeffer R.C., Gratrix M.L., Mucha D.R., et al. The rat glomerular filtration barrier does not show negative charge selectivity. Microcirculation 2002, 9:329-342.
297. Schenk O., Ling H., Sebekova K., et al. High glucose media enhance the responsiveness of tubular cells to growth promoters: effect on lysosomal cathepsins and protein degradation. Miner Electrolyte Metab 1998, 24:254-260.
298. Schnabel E., Anderson J.M., Farquhar M.G. The tight junction protein ZO-1 is concentrated along the slit diaphragms of the glomerular epithelium. J Cell Biol 1990, 111:1255-1261.
299. Schwarz K., Simons M., Reiser J., et al. Podocin, a raft-associated component of the glomerular slit-diaphragm, interacts with CD2AP and nephrin. J Clin Invest 2001, 108:1621-1629.
300. Schwegler J.S., Heppelmann B., Mildenberger S., et al. Receptor-mediated endocytosis of albumin in cultured opossum kidney cells: a model for proximal tubular protein reabsorption. Pflügers Arch 1991, 418:383-392.
301. Seikaly M.G., Arant B., Seney F.D. Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J Clin Invest 1990, 86:1352-1357.
302. Shaw M., Schy A. Exclusion in hyaluronate gels. Biophys J 1977, 17:47-55.
303. Shih N.Y., Li J., Karpitskii V., Nguen A., et al. Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science 1999, 286:312-315.
304. Sidaway J.E., Davidson R.G., McTaggart F., et al. Inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase reduce receptor-mediated endocytosis in opossum kidney cells. J Am Soc Nephrol 2004, 15:2258-2265.
305. Simons M., Schwarz K., Kriz W., et al. Involvement of lipid rafts in nephrin phosphorylation and organization of the glomerular slit diaphragm. Am J Pathol 2001, 159:1069-1077.
306. Smit M.F., Comper W.D. A codiffusing system as a novel model for capillary wall charge selectivity. Biophys Chem 1996, 62:73-80.
307. Smit M.F., Pratt L.M., Comper W.D. Conformational dependence of the fractional clearance of dextran and Ficoll. Nephrology 1996, 2:355-360.
308. Smithies O. Why the kidney glomerulus does not clog: a gel permeation/diffusion hypothesis of renal function. Proc Natl Acad Sci U S A 2003, 100:4108-4113.
309. Snowden J., Maroudas A. Distribution of serum albumin in human normal and degenerate cartilage. Biochim Biophys Acta 1976, 428:726-740.
310. Sörensson J., Bjornson A., Ohlson M., et al. Synthesis of sulfated proteoglycans by bovine glomerular endothelial cells in culture. Am J Physiol 2003, 284:F373-F380.
311. Sörensson J., Ohlson M., Haraldsson B. A quantitative analysis of the glomerular charge barrier in the rat. Am J Physiol 2001, 280:F646-F656.
312. Stehouwer C.D.A., Nauta J.J.P., Zeldenhurst G.C., et al. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 1992, 340:319-323.
313. Stehouwer C.D.A. Endothelial dysfunction in diabetic nephropathy: state of the art and potential significance for non-diabetic renal disease. Nephrol Dial Transplant 2004, 19:778-781.
314. Steinmeyer K., Schwappach B., Bens M., et al. Cloning and functional expression of rat CLC-5, a chloride channel related to kidney disease. J Biol Chem 1995, 270:31172-31177.
315. 131-tagged albumin. J Clin Invest 1951, 30:1228-1237.
316. Strobel J.L., Cady S.G., Borg T.K., et al. Identification of fibroblasts as a major site of albumin catabolism in peripheral tissues. J Biol Chem 1986, 261:7989-7994.
317. Strober W., Waldmann T.A. The role of the kidney in the metabolism of plasma proteins. Nephron 1974, 13:35-66.
318. Strong K.J., Osicka T.M., Comper W.D. Urinary peptide excretion by non-diabetic volunteers and diabetic patients. J Lab Clin Med 2005, 145:239-246.
319. Sugimoto H., Hamano Y., Chartytan D., et al. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor (SFlt-1) induces proteinuria. J Biol Chem 2003, 278:12605-12608.
320. Suzuki H., Schaefer L., Ling H., et al. Prevention of cardiac hypertrophy in experimental chronic renal failure by long-term ACE inhibitor administration: Potential role of lysosomal proteinases. Am J Nephrol 1995, 15:129-136.
321. Takano M., Nakanishi N., Kitahara Y., et al. Cisplatin-induced inhibition of receptor-mediated endocytosis of protein in the kidney. Kidney Int 2002, 62:1707-1717.
322. Tanner G.A., Wang E., Williams J.C. Measurement of glomerular filterability of fluorescent macromolecules by 2-photon microscopy. J Am Soc Nephrol 2004, 15:211A.
323. Tencer J., Frick I.M., Oqvist B.W., et al. Size-selectivity of the glomerular barrier to high molecular weight proteins: upper size limitations of shunt pathways. Kidney Int 1998, 53:709-715.
324. Terui J., Tamoto K., Sudo J. Proteinuric potentials of angiotensin II, [des-Asp1]-angiotensin II and [des-Asp1,des-Asp2]-angiotensin II in rats. Biol Pharm Bull 1994, 17:1516-1518.
325. Thomas D.M., Coles G.A., Griffiths D.F., et al. Permselectivity in thin membrane nephropathy. J Clin Invest 1994, 93:1881-1884.
326. Thomas M.E., Morrison A.R., Schreiner G.F. Metabolic effects of fatty acid-bearing albumin on a proximal tubule cell line. Am J Physiol 1995, 37:F1177-F1184.
327. Thomas M.E., Schreiner G.F. Contribution of proteinuria to progressive renal injury: consequences of tubular uptake of fatty acid bearing albumin. Am J Nephrol 1993, 13:385-398.
328. Thongboonkerd V., McLeish K.R., Arthur J.M., et al. Proteomic analysis of normal human urinary proteins isolated by acetone precipitation or ultracentrifugation. Kidney Int 2002, 62:1461-1469.
329. Tojo A., Endou H. Intrarenal handling of proteins in rats using fractional micropuncture technique. Am J 1992, 263:F601-F606.
330. Tojo A., Onozato M.L., Kurihara H., et al. Angiotensin II blockade restores albumin reabsorption in the proximal tubules of diabetic rats. Hypertens Res 2003, 26:413-419.
331. Topham P.S., Kawachi H., Haydar S.A., et al. Nephritogenic mAb 5-1-6 is directed at the extracellular domain of rat nephrin. J Clin Invest 1999, 104:1559-1566.
332. Toto R.D. Proteinuria and hypertensive nephrosclerosis in African-Americans. Kidney Int 2004, 66(Suppl 92):102-104.
333. Tryggvason K., Pettersson E. Causes and consequences of proteinuria: the kidney filtration barrier and progressive renal failure. J Int Med 2003, 254:216-224.
334. Tryggvason K., Wartiovaara J. Molecular basis of glomerular permselectivity. Curr Opin Nephrol Hypertens 2001, 10:543-549.
335. Van den Berg J.G., Weerman M.A., Assmann K.J.M., et al. Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies. Kidney Int 2004, 66:1901-1906.
336. Van den Born J., van den Heuvel L.P.W.J., Bakker M.A.H., et al. A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. Kidney Int 1992, 41:115-123.
337. Van Kerkhof P., Alves dos Santos C.M., Sachse M., et al. Proteasome inhibitors block a late step in lysosomal transport of selected membrane but not soluble proteins. Mol Biol Cell 2001, 12:2556-2566.
338. Viberti G.C., Hill R.D., Jarrett R.J., et al. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982, 1:1430-1432.
339. Vyas S.V., Burne M.J., Pratt L.M., et al. Glomerular processing of dextran sulphate. Arch Biochem Biophys 1996, 332:205-212.
340. Wachtell K., Ibsen H., Olsen M.H., et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med 2003, 139:901-906.
341. Waldman T.A. Albumin catabolism. Albumin Structure, Function and Uses 1977, 255-273. Pergamon, New York. V.M. Rosenoer, M. Oratz, M.A. Rothschild (Eds.).
342. Wang S., Chen Q., Strebeck F., et al. Bone morphogenetic protein-7(BMP-7), a novel therapy for diabetic nephropathy. Kidney Int 2003, 63:2037-2049.
343. Wartiovaara J., öfverstedt L.-G., Khoshnoodi J., et al. Nephrin strands contribute to a porous slit diaphragm scaffold as revealed by electron tomography. J Clin Invest 2004, 114:1475-1483.
344. Weening J.J., Rennke H.G. Glomerular permeability and polyanion in Adriamycin nephrosis in the rat. Kidney Int 1983, 24:152-159.
345. Weening J.J., Van Guldener C., Daha M.R., et al. The pathophysiology of protein-overload proteinuria. Am J Pathol 1987, 129:64-73.
346. Weir M.R. Microalbuminuria in type 2 diabetes: An important, overlooked cardiovascular risk factor. J Clin Hypertens 2004, 6:134-143.
347. Weissinger E.M., Wittke S., Kaiser T., et al. Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes. Kidney Int 2004, 65:2426-2434.
348. Welsch T., Endlich N., Kriz W., et al. CD2AP and p130Cas localize to different F-actin structures in podocytes. Am J Physiol 2001, 281:F769-F777.
349. Whiteside C., Silverman M. Determination of glomerular permselectivity to neutral dextrans in the dog. Am J Physiol 1983, 245:F485-F495.
350. Wiggins R.C., Kshrisagar B., Kelsch R.C., et al. Fragmentation and polymeric complexes of albumin in human urine. Clin Chim Acta 1985, 149:155-163.
351. Winocour P.H., Harland J.O., Millar J.P., et al. Microalbuminuria and associated cardiovascular risk factors in the community. Atherosclerosis 1992, 93:71-81.
352. Winzor D.J., Carrington L.E., Deszczynski M., et al. The extent of charge screening in aqueous polysaccharide solutions. Biomacromolecules 2004, 5:56-60.
353. Wittke S., Fliser D., Haubitz M., et al. Determination of peptides and proteins in human urine with capillary electrophoresis-mass spectrometry, a suitable tool for the establishment of new diagnostic markers. J Chromatogr 2003, 1013:173-181.
354. Wolf G., Ziyadeh F.N., Stahl R.A. Angiotensin II stimulates expression of transforming growth factor beta receptor type II in cultured mouse proximal tubule cells. J Mol Med 1999, 77:556-564.
355. Wolf G., Ziyadeh F.N. Renal tubular hypertrophy induced by angiotensin II. Semin Nephrol 1997, 17:448-454.
356. Wolgast M., Källskog O., Wahlström H. Characteristics of the glomerular capillary membrane of the rat kidney as a hydrated gel, II: on the validity of the model. Acta Physiol Scand 1996, 158:225-232.
357. Wright E.M., Hirsch J.R., Loo D.P.F., et al. Regulation of Na+/glucose cotransporters. J Exp Biol 1997, 200:287-293.
358. Yagame M., Suzuki D., Jinde K, et al. Urinary albumin fragments as a new clinical parameter for the early detection of diabetic nephropathy. Int Med 1995, 34:463-468.
359. Yedgar S., Carew T.E., Pittman R.C., et al. Tissue sites of catabolism of albumin in rabbits. Am J Physiol 1983, 244:E101-E107.
360. Yu D., Petermann A., Kunter U., et al. Urinary podocyte loss is a more specifc marker of ongoing glomerular damage than proteinuria. J Am Soc Nephrol 2005, 16:1733-1741.
361. Yu L., Border W.A., Huang Y., et al. TGF-beta isoforms in renal fibrogenesis. Kidney Int 2003, 64:844-856.
362. Yuan H., Takeuchi E., Salant D.J. Podocyte slit-diaphragm protein nephrin is linked to the actin cytoskeleton. Am J Physiol 2002, 282:F585-F591.
363. Yudkin J.S., Forrest R.D., Jackson C.A. Microalbuminuria as a predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet 1988, 2:530-533.
364. Yuyun M.F., Khaw K.T., Luben R., et al. Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: The European Prospective Investigation into Cancer in (EPIC-Norfolk) population study. Int J Epidemiol 2004, 33:189-198.
365. Zamparo O., Comper W.D. Model anionic polysaccharide matrices exhibit lower charge selectivity than is normally associated with kidney ultrafiltration. Biophys Chem 1990, 38:167-178.
366. Zhou X., Li C., Dlugosz J., et al. Mesangial cell actin disassembly in high glucose mediated by protein kinase C and the polyol pathway. Kidney Int 1998, 53:1608-1615.